SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
Public ClinicalTrials.gov record NCT02544204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2B Randomized Double Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as Adjunct to Revascularization of Infrapopliteal Lesions in Subjects With Advanced Peripheral Artery Disease and Tissue Loss
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To investigate the efficacy of the administration of JVS-100 delivered via direct intramuscular injections on a 3 month and 6 month composite endpoint of wound progression, healing and limb loss in patients with severe peripheral arterial disease with non-healing chronic wounds who undergo an open bypass grafting or endovascular procedure for treatment of infrapopliteal disease and are dosed within 12 days and 3 months following the procedure.
Study identification
- NCT ID
- NCT02544204
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2015 (Type not available)
- Primary completion
- Sep 2017 (Estimated)
- Completion
- Nov 2017 (Estimated)
- Last update posted
- Nov 2, 2016
2015 – 2017
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiovascular Associates of the Southeast | Birmingham | Alabama | — | Not yet recruiting |
| UC Davis | Davis | California | — | Recruiting |
| Cedars-Sinai Heart Institute | Los Angeles | California | — | Recruiting |
| MedStar Georgetown UH | Washington D.C. | District of Columbia | — | Not yet recruiting |
| Morton Plant Hosptial - Baycare | Clearwater | Florida | — | Recruiting |
| Mount Sinai Medical Center | Miami | Florida | — | Recruiting |
| St. Joseph's Hospital | Tampa | Florida | 33614 | Recruiting |
| Northwestern | Chicago | Illinois | — | Recruiting |
| RUMC | Chicago | Illinois | — | Recruiting |
| Cardiovascular Institute of the South | Houma | Louisiana | — | Recruiting |
| St. John Hospital and Medical Center | Detroit | Michigan | — | Recruiting |
| Mayo | Rochester | Minnesota | — | Recruiting |
| Cardiology Associates Research | Tupelo | Mississippi | — | Recruiting |
| St. Luke's Mid America Heart Institute | Kansas City | Missouri | — | Recruiting |
| Holy Name Medical Center | Teaneck | New Jersey | — | Recruiting |
| UNC | Chapel Hill | North Carolina | — | Recruiting |
| NC Heart and Vascular Research | Raleigh | North Carolina | — | Recruiting |
| Summa Health | Akron | Ohio | — | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | — | Recruiting |
| Metro Health | Cleveland | Ohio | — | Recruiting |
| University Hospitals | Cleveland | Ohio | — | Recruiting |
| Lifespan Health System | Providence | Rhode Island | — | Recruiting |
| VCU | Richmond | Virginia | — | Recruiting |
| Medical College of Wisconsin | Milwauke | Wisconsin | — | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02544204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2016 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02544204 live on ClinicalTrials.gov.